https://www.selleckchem.com/pr....oducts/Gefitinib.htm
To study the influence of different treatments on the prognosis of patients with head and neck lymphoma (HNL). A single center retrospective study was conducted on 301 patients with HNL diagnosed from 2015 to 2020, compare the disease-free survival rate of patients treated surgically or conservatively. For indolent non-Hodgkin's lymphoma (iNHL), there is no significant difference in the prolongation of disease-free survival time between surgery and conservative treatment (P0.05). For iNHL especially in glands, we can adopt wide lo
Like
Comment
Share
